Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries26. September 2025
News Samsung to acquire digital health firm XealthHealthradar10. Juli 2025 Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:…
News Samsung Acquires Xealth to Accelerate Connected Care VisionHealthradar8. Juli 2025 What You Should Know: – Samsung Electronics Co., Ltd. today announced it has signed an agreement to acquire Xealth, a…
